Article | October 9, 2024

Avoiding FDA Recalls: A Blueprint For Life Sciences Companies

By James Jardine, GxP Lifeline Editor, MasterControl

GettyImages-496318694 pharmaceutical

FDA product recalls can be a devastating blow. With increasing frequency and severe consequences, it's imperative for companies to prioritize prevention. This article delves into the root causes of recalls and explores effective strategies to mitigate risks.

Discover how a robust quality management system (QMS) can serve as a cornerstone in preventing recalls. Learn about the importance of proactive risk assessment, rigorous testing, and vigilant monitoring. Explore the benefits of leveraging advanced technologies, such as electronic batch records (EBRs) and electronic design history records (eDHRs), to streamline processes and enhance compliance.

By implementing these strategies, life sciences companies can significantly reduce the likelihood of recalls, protect their reputation, and safeguard the health and safety of consumers. Don't let product recalls become a reality. Take proactive steps today to ensure the quality and integrity of your products.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma